Premium Information is available for this item - Upgrade for $1 a day
6505-01-091-7535
Usp Aspirin And Codeine Phosphate Tablets
6505010917535 010917535 NDC00081-0225-25 0081-0225-25 374 EMPIRIN W/ CODEINE
November 2023
9
Marketplace 6505-01-091-7535
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-091-7535 5+ Documents (More...)
Codeine Phosphate Tablets Phosphate Tablets6505001182347 001182347 NDC00081-0220-25 ASCODEEN EMPIRIN W/CODEINE
DAC 4 ASCODEEN 09979 AMC 0 AMSC 0 AAC L Approved Sources 6505-01-091-7535 Part NumberManufacturerStatusNDC00081
Usp Aspirin And Codeine Phosphate Tablets 6505-01-091-7535 https//www.nsnlookup.com /fsg-65/fsc
65/fsc-6505/us 6505-00-118-2347 Usp Aspirin And Codeine Phosphate Tablets fsg-65/fsc-6505/us 6505-01-091-7535
33-189-8666 6505-33-000-4040 Aspirin And Codeine Phosphate Tablets 149-0116 6505-01-086-1992 6505-01-091-7535
33-189-8666 6505-33-000-4040 Aspirin And Codeine Phosphate Tablets 149-0116 6505-01-086-1992 6505-01-091-7535
to 6505-00-959-4331 6505-00-118-2347 6505-00-149-0116 5 RNVC 9 DAC 4 EMPIRIN W/CODEINE Stock Numbers
Related to 6505-00-118-2347 6505-00-118-2347 6505-00-149-0116 6505-01-086-1992 6505-01-091-7535 https
Usp Aspirin And Codeine Phosphate Tablets 6505-00-149-0116 6505-01-086-1992 6505-01-091-7535 Stock
/es 6505-33-000-4040 Aspirin And Codeine Phosphate Tablets 6505-00-149-0116 6505-01-086-1992 6505-01-091-7535
Restrictions 6505-01-091-7535
6505-01-091-7535 is a Usp Aspirin And Codeine Phosphate Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
End Users 6505-01-091-7535
- NASA (G65V)
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-091-7535
- Part Number
- Manufacturer
- Status
- NDC00081-0225-25
- Manufacturer
- 09979 - Burroughs Wellcome Co (Obsolete)
- Primary Buy
- Primary Buy
- 0081-0225-25
- 09979 - Burroughs Wellcome Co (Obsolete)
- Primary Buy
- Primary Buy
- 374
- 09979 - Burroughs Wellcome Co (Obsolete)
- Canceled/Obsolete
- Canceled/Obsolete
- EMPIRIN W/ CODEINE
- 09979 - Burroughs Wellcome Co (Obsolete)
- Canceled/Obsolete
- Canceled/Obsolete
Datasheet 6505-01-091-7535
- Characteristic
- Specifications
- Active Medicament Medicinal Strength [AKJA]
- Specifications
- 60.000 Milligrams Codeine Phosphate Active Ingredient And 325.000 Milligrams Aspirin Active Ingredient
- Administration [CSGS]
- Oral
- Primary Container Type [CQCT]
- Strip, Roll
- Primary Container Content Quantity [CRLK]
- 25.000 Tablets
- Special Features [FEAT]
- Reverse Numbered Strip
- Total Primary Container Quantity [CSCW]
- 1
NATO Stock Numbers Related to 6505-01-091-7535
Freight Information 6505-01-091-7535
6505-01-091-7535 has freight characteristics.. 6505-01-091-7535 has a variance between NMFC and UFC when transported by rail and the description should be consulted.